Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Montgomery

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Journal of Psychiatric Research|June 30, 2026
Cumulative depressive burden, functional impairment, depressive symptomatology and treatment response in Major Depressive Disorder: results from the STAR∗D and GSRD studiesMaria Luca, Paolo Olgiati, Antonina Luca, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 30, 2013
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patientsRaffaella Calati, Concetta Crisafulli, Martina Balestri, et al.
Depression and Anxiety|June 10, 2021
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Neuroscience Letters|April 11, 2012
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depressionJulien Mendlewicz, Concetta Crisafulli, Raffaella Calati, et al.
Journal of Affective Disorders|January 25, 2025
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sexMaria Luca, Antonina Luca, Antonino Messina, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 29, 2021
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseGiuseppe Fanelli, Katharina Domschke, Alessandra Minelli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 29, 2025
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disordersPaolo Abondio, Giuseppe Fanelli, Valentina Baldini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysisVincenzo Oliva, Chiara Possidente, Giuseppe Fanelli, et al.
Neuroscience Letters|January 17, 2020
Genetic variants associated with psychotic symptoms across psychiatric disordersMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Journal of Psychiatric Research|June 30, 2026
Cumulative depressive burden, functional impairment, depressive symptomatology and treatment response in Major Depressive Disorder: results from the STAR∗D and GSRD studiesMaria Luca, Paolo Olgiati, Antonina Luca, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 30, 2013
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patientsRaffaella Calati, Concetta Crisafulli, Martina Balestri, et al.
Depression and Anxiety|June 10, 2021
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Neuroscience Letters|April 11, 2012
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depressionJulien Mendlewicz, Concetta Crisafulli, Raffaella Calati, et al.
Journal of Affective Disorders|January 25, 2025
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sexMaria Luca, Antonina Luca, Antonino Messina, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 29, 2021
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseGiuseppe Fanelli, Katharina Domschke, Alessandra Minelli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 29, 2025
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disordersPaolo Abondio, Giuseppe Fanelli, Valentina Baldini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysisVincenzo Oliva, Chiara Possidente, Giuseppe Fanelli, et al.
Neuroscience Letters|January 17, 2020
Genetic variants associated with psychotic symptoms across psychiatric disordersMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.
Pageof 12